Analysis of the sputum and inflammatory alterations of the airways in patients with common variable immunodeficiency and bronchiectasis

Clinics

Volumn 64, Issue 12, 2009, Pages 1155-1160

  Pereira, Andrea Cristina ^a   Kokron, Cristina M ^a   Romagnolo, Beatriz Mangueira Saraiva ^a   Yagi, Claudia Simeire Albertini ^a   Saldiva, Paulo Hilário Nascimento ^a   Filho, Geraldo Lorenzi ^a   Negri, Elnara Marcia ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL SÍRIO LIBANÊS   (Brazil)

Author keywords

Airway inflammation; IVIG; Pulmonary defense mechanisms; Pulmonary infection; Sputum

Indexed keywords

EID: 75649146562     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322009001200004     Document Type: Article

References (29)

1. Kokron CM, Errante PR, Barros MT, Baracho GV, Camargo MM, Kalil J, et al. Clinical and laboratory aspects of common variable immunodeficiency. Anais da Academia Brasileira de Ciências.2004;76:707-26.
2. Yong PF, Tarzi M, Chua I, Grimbacher B, Chee R. Common variable immunodeficiency: an update on etiology and management. Immunol. Allergy Clin North Am. 2008;28:367-86.
3. King P, Holdsworth S, Freezer N, Holmes P. Bronchietasis. Inter. Med. J. 2007; 37:208-9.
4. Oksenhendler E, Gérard L, Fieschi C, Malphettes M, Mouillot G, Jaussaud R, et al. Infections in 252 patients with common variable immunodeficiency. Clinical Infect Dis. 2008;46:1547-54.
5. Stannard W, O'Callaghan C. Ciliary function and the role of cilia in clearance. J Aerosol Med. 2006;19:110-5.
6. Willems T, Jorissen M. Correlations between ciliary structure and ciliary function. Acta Otorhinolaryngol Belg. 2000;54:299-308.
7. Lorenzi-Filho G, Bohm GM and Guimarães ET. Correlation between rheologic properties and in vitro ciliary transport of rat nasal mucus. Biorheology 1992;29:433-40.
8. Smith DJ, Gaffney EA, Blake JR. Modelling mucociliary clearance. Respir Physiol Neurobiol. 2008;163:178-88.
9. Del Donno M, Bittessnich D, Chetta A, Olivieri D and Lopez-Vidriero M. The effect of inflammation on mucociliary clearance in asthma: an overview. Chest. 2000;118:1142-9.
10. Wills P and Greenstone M. Inhaled hyperosmolar agents for bronchiectasis, Cochrane Database Syst Rev. 2006;CD002996.
11. Jolles S, Sewell WAC and Misbah SA. Clinical uses of intravenous immunoglobulin. Clinical and Experimental Immunology. 2005;142:1-11.
12. Busse PJ, Farzan S, Cunningham-Rundles C. Pulmonary complications of common variable immunodeficiency. Ann Allergy Asthma Immunol 2007;98:1-8;quiz 8-11,43.
13. de Gracia J, Vendrell M, Alvarez A, Pallisa E, Rodrigo MJ, de la Rosa D, et al. Immunoglobulin Therapy to control lung damage in patients with common variable immunodeficiency. International Immunopharmacology. 2004;4:745-53.
14. King P, Holdsworth P, Freezer N, Holmes P. Bronchiectasis. Internal Medicine Journal. 2006;36:729-37.
15. Leme AS, Kasahara DI, Nunes MP, Martins MA and Vieira JA. Exhaled nitric oxide collected with two different mouthpieces: a study in asthmatic patients. Braz J Med Biol Res. 2002;35:1133-7.
16. Saraiva-Romanholo MB, Barnabé V, Carvalho AL, Martins MA, Saldiva PHN and Nunes MP. Comparison of three methods for differential cell count in induced sputum Chest. 2003;124:1060-6.
17. Pizzichini E, Pizzichini MM, Efthimiadis A, Hargreave FE, Dolovich J. Measurement of inflammatory indices sputum: effects of selection of sputum to minimize salivary contamination. Eur Respir J. 1996;9:1174-80.
18. Trindade SHK, Mello Júnior JF, Mion OG, Lorenzi-Filho G, Macchione M, Guimarães ET, et al. Methods for studying mucociliary transport. Rev. Bras. Otorrinolaringol. 2007;73:704-12.
19. King M. Clearance of mucus by simulated cough. J Appl Physiol. 1985;58:1776-82.
20. Pasteur MC, Helliwell SM, Houghton SJ, Webb SC, Foweraker JE, Coulden RA, et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med. 2000; 162(4Pt1):1277-84.
21. Stead A, Douglas JG, Broadfoot CJ, Kaminski ER and Herriot RT. Humoral immunity and bronchiectasis. Clinical and Experimental Immunology. 2002;130:325-30.
22. Daviskas E, Andreson SD, Gomes K. Inhaled mannitol for the treatment of mucociliary function in patients with bronchiectasis: effect on lung function, health status and sputum. Respirology. 2005;10:46-56.
23. Barker AF. Medical progress: bronchiectasis. New England Journal of Medicine. 2002;346:1383-93.
24. Mouthon L, Kaveri SV, Spalter SH, Lacroix-Desmazes S, Lefranc C, Desai R, et al. Mechanisms of actions of intravenous immune globulin in immune-mediated diseases. Clin. Exp. Immunol 1996;104 (suppl.1):3-9.
25. Pourpak Z, Aghamohammadi A, Sedighipour L, Farhoudi A, Movahedi M, Gharagozlou M, et al. Effect of regular intravenous immunoglobulin therapy on prevention of pneumonia in patients with common variable immunodeficiency. J Microbiol Immunol Infect. 2006;39:114-20.
26. Mouthon L. Intravenous immunoglobulin therapy. Rev Prat. 2005;55:1049-56.
27. D'Ippolito R, Chetta A, Foresi A. Induced sputum and bronchoalveolar lavage from patients with hypersensitivity pneumonitis. Respir Med. 2004;98:977-83.
28. Arjomandi M, Schmidlin I, Girling P, Boylen K, Ferrando R and Balmes J. Sputum induction and bronchoscopy for assessment of ozone-induced airway inflammation in asthma. Chest. 2005;128:416-23.
29. Ziora D, Kaluska K, Rauer R, Kozielisk J. Concentration of nitric oxide exhaled air in patients with CPOD and bronchiectasis. Pneumol Alergol Pol. 2003;71:418-27.